Correction to: Trials 22, 566 (2021)
https://doi.org/10.1186/s13063-021-05529-6
Following the publication of the original article [1], we were notified that the first affiliation of the first author was incorrect.
-
Originally published affiliation: School of Nursin, Shandong First Medical University (Shandong Academy of Medical Sciences), Jinan 250000, Shandong, China
-
Corrected affiliation: School of Public Health, Xinxiang Medical University, Xinxiang 453003, Henan, China
The original article has been corrected.
Reference
Gao, et al. Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial. Trials. 2021;22:566. https://doi.org/10.1186/s13063-021-05529-6.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Gao, LL., Li, YX., Ma, JM. et al. Correction to: Effect of Lycium barbarum polysaccharide supplementation in non-alcoholic fatty liver disease patients: study protocol for a randomized controlled trial. Trials 22, 672 (2021). https://doi.org/10.1186/s13063-021-05649-z
Published:
DOI: https://doi.org/10.1186/s13063-021-05649-z